Řezníčková Eva

Journals

JORDA, R., Z. BUCKOVA, E. ŘEZNÍČKOVÁ, J. BOUCHAL, V. KRYŠTOF
Selective inhibition reveals cyclin-dependent kinase 2 as another kinase that phosphorylates the androgen receptor at serine 81. Biochimica et Biophysica Acta. 2018, 1865(2), 354-363, ISSN: 0006-3002, PMID: 29157894,  PDF.
ŘEZNÍČKOVÁ, E., A. POPA, T. GUCKÝ, M. ZATLOUKAL, L. HAVLICEK, V. BAZGIER, K. BERKA, R. JORDA, I. POPA, A. NASEREDDIN, C. JAFFE, V. KRYŠTOF, M. STRNAD
2,6,9-Trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro. Bioorganic and Medicinal Chemistry Letters. 2015, 25(11), 2298-2301, ISSN: 0960-894X, PMID: 25937014,
GUCKÝ, T., E. ŘEZNÍČKOVÁ, P. DŽUBÁK, M. HAJDÚCH, V. KRYŠTOF
Synthesis and anticancer activity of some 1,5-diaryl-3-(3,4,5-trihydroxyphenyl)-1H-pyrazolo[4,3-e][1,2,4]triazines. Monatshefte fur Chemie. 2010, 141(6), 709-714, ISSN: 0026-9247,